Navigation Links
Express Scripts’ Miller Discusses Loss of ‘Social Contract’ in Drug Pricing, Other Specialty Pharmacy Trends
Date:7/21/2015

The “social contract” that once existed among pharmaceutical companies, investors, and the public kept drug costs within reach of those who needed them. But that contract has broken down, leading to drug prices that are “entirely dissociated” with the cost of bringing them to market, Steve Miller, MD, the chief medical officer of Express Scripts, said in an interview published today.

In a wide-ranging discussion with Evidence-Based Diabetes Management, a publication of The American Journal of Managed Care, Dr. Miller describes the changed environment PBMs face as they seek to hold down drug prices for health plans and major employers, and, by extension, consumers. Express Scripts is the nation's leading PBM organization.

Among the challenges, Dr. Miller said, is the philosophy toward drug development that exists today. “Drug companies and Wall Street analysts clearly believe that if you have a unique therapy and if you have the patent, then you have almost unlimited pricing power,” he said.

“Thank goodness this line of thinking wasn’t used with the polio vaccine in the 1950s and 60s, or nobody would have been able to afford it,” Dr. Miller said. For the full interview, click here.

When Sovaldi hit the market with a 12-week course of $84,000, critics decried the “$1,000 pill,” while supporters of granting patients access said it would prevent those with hepatitis C from needing further treatment, including liver transplants (1). Competitors have come on the market since then, and Dr. Miller describes the approach Express Scripts has taken to bringing down costs, which requires buy-in from its customers. As new breakthrough therapies near FDA approval, there’s more discussion between pharmacy benefit managers and drugmakers on the front end than in the past, he said.

That approach will be tested soon. The FDA is expected to act this week on the first of two cholesterol-fighting PCKS9 inhibitors that face summer deadlines. Alirocumab, to be marketed as Pralunet by Regeneron and Sanofi, faces a deadline of Friday for FDA action.

(1) Goozner, M. Why Sovaldi shouldn't cost $84,000. Modern Healthcare. May 3, 2014.

About the Journals

The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on new healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s news publications, the Evidence-Based series, bring together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.

CONTACT:    
Nicole Beagin (609) 716-7777 x 131
nbeagin(at)ajmc(dot)com    
http://www.ajmc.com

Read the full story at http://www.prweb.com/releases/2015/07/prweb12862615.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. North Valley Hospital Uses Summit Express Connect to Integrate 45 Interfaces During EHR Migration
2. Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL
3. MBLM’s One-Month, In-Depth Study of Apple Watch Users Reveals that Millennials Express Dissatisfaction and Guilt
4. Brooklyn Dentist Dr. Leonard Umanoff, DDS Will Offer Invisalign Express as Smart Solution for Mildly Misaligned Teeth
5. Global Expression Vectors Market to Grow at a 5.5% CAGR from 2015 to 2020 to Reach Over $300 Million Mark
6. Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic
7. Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP
8. Debut Author Shirley Montoute Expresses ‘Emotions of a Lifetime’
9. Survey Reveals High School Students' and College Students’ Favorite Sports, Exercise Habits, Diet: New CollegeXpress Infographic
10. Learning ZoneXpress announces new educational resource to celebrate National Physical Fitness and Sports Month
11. Harbor Village Detox Expresses Concern About the Working Class Abusing Adderall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: